Anticancer Pharmacology

Tyrosine Kinase Inhibitors (TKI) + Chemotherapy in NSCLC (EGFR⁺)
Gefitinib (Iressa) + Pemetrexed/carbplatin (example) in EGFR⁺ Non-Small Cell Lung Adenocarcinoma (Click to go to Content)

Attribution: Levy BP Gadgeel SM Tsao AS Bazhenova LA Frontline Chemo and TKI Combination in EEGFR + NSCLC https://www.youtube.com/watch?v=IUQcHcGBh4Q Onclive4TV Youtube Channel: https://www.youtube.com/channel/UC3aRpa3CR_w4JrxYv_r_pDg